Victory Capital Management Inc Veracyte, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 85,443 shares of VCYT stock, worth $3.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,443

Previous 87,555 2.41%

Holding current value

$3.61 Million

Previous $1.9 Million 53.24%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$21.0 - $35.25 $44,352 - $74,448	-2,112 Reduced 2.41%	85,443 $2.91 Million
Q2 2024 Aug 05, 2024	BUY	$18.86 - $23.55 $295,102 - $368,486	15,647 Added 21.76%	87,555 $1.9 Million
Q1 2024 May 03, 2024	BUY	$21.0 - $29.1 $13,629 - $18,885	649 Added 0.91%	71,908 $1.59 Million
Q4 2023 Feb 05, 2024	BUY	$19.72 - $28.68 $280,398 - $407,800	14,219 Added 24.93%	71,259 $1.96 Million
Q3 2023 Nov 06, 2023	BUY	$22.33 - $29.92 $3,059 - $4,099	137 Added 0.24%	57,040 $1.27 Million
Q2 2023 Jul 27, 2023	BUY	$20.96 - $26.99 $824,482 - $1.06 Million	39,336 Added 223.92%	56,903 $1.45 Million
Q1 2023 May 02, 2023	BUY	$20.58 - $27.89 $361,528 - $489,943	17,567 New	17,567 $391,000
Q3 2022 Nov 02, 2022	SELL	$16.58 - $27.9 $816,515 - $1.37 Million	-49,247 Reduced 52.85%	43,929 $729,000
Q2 2022 Aug 01, 2022	BUY	$15.45 - $29.52 $592,183 - $1.13 Million	38,329 Added 69.88%	93,176 $1.85 Million
Q1 2022 May 04, 2022	BUY	$21.94 - $42.51 $1,886 - $3,655	86 Added 0.16%	54,847 $1.12 Million
Q4 2021 Feb 07, 2022	SELL	$36.09 - $53.79 $315,137 - $469,694	-8,732 Reduced 13.75%	54,761 $2.26 Million
Q3 2021 Nov 02, 2021	SELL	$35.62 - $52.97 $124,954 - $185,818	-3,508 Reduced 5.24%	63,493 $2.95 Million
Q2 2021 Aug 03, 2021	SELL	$32.94 - $56.62 $35,443 - $60,923	-1,076 Reduced 1.58%	67,001 $2.68 Million
Q1 2021 May 04, 2021	SELL	$44.47 - $81.38 $213,144 - $390,054	-4,793 Reduced 6.58%	68,077 $3.66 Million
Q4 2020 Feb 01, 2021	SELL	$32.49 - $61.88 $220,087 - $419,175	-6,774 Reduced 8.51%	72,870 $3.57 Million
Q3 2020 Nov 09, 2020	SELL	$26.73 - $35.67 $682,817 - $911,190	-25,545 Reduced 24.28%	79,644 $2.59 Million
Q2 2020 Aug 07, 2020	SELL	$19.49 - $28.11 $1,266 - $1,827	-65 Reduced 0.06%	105,189 $2.72 Million
Q1 2020 May 04, 2020	BUY	$16.13 - $30.17 $20,743 - $38,798	1,286 Added 1.24%	105,254 $2.56 Million
Q4 2019 Feb 06, 2020	BUY	$20.78 - $29.99 $36,552 - $52,752	1,759 Added 1.72%	103,968 $2.9 Million
Q4 2019 Feb 04, 2020	BUY	$20.78 - $29.99 $138,311 - $199,613	6,656 Added 6.97%	102,209 $2.68 Million
Q3 2019 Nov 12, 2019	BUY	$23.87 - $30.93 $2.28 Million - $2.96 Million	95,553 New	95,553 $2.29 Million
Q1 2019 May 03, 2019	SELL	$12.0 - $25.76 $2.65 Million - $5.7 Million	-221,200 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$9.15 - $14.85 $80,520 - $130,680	-8,800 Reduced 3.83%	221,200 $2.78 Million
Q3 2018 Nov 01, 2018	BUY	$9.55 - $12.64 $2.2 Million - $2.91 Million	230,000 New	230,000 $2.2 Million

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.02B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Veracyte, Inc. Transaction History